Beauty Health is a medical aesthetics company built around Hydrafacial, a noninvasive skincare treatment delivered through a proprietary device in professional settings. The Hydrafacial treatment is a three-step cleanse, extract, and hydrate process performed using a patented pneumatic suction system with proprietary solutions and serums. The treatment takes under an hour, works across all skin types, and can be repeated every 30 days, making it a routine skincare offering rather than a one-off procedure. Beauty Health sells to licensed providers — dermatologists, plastic surgeons, med spas, estheticians, and day spas — with the medical channel accounting for roughly 70% of U.S. and Canada sales. The company operates on a razor/razor blade model: providers purchase the device as a capital equipment item, then repeatedly buy single-use tips, solutions, and serums for every treatment performed. Consumables represent over 70% of total net sales and generate recurring, high-margin revenue. The installed base stood at approximately 35,400 active units globally as of late 2025, with average annual consumable revenue per device running around $6,300. Beyond base consumables, Beauty Health sells optional "Booster" serums targeting specific skin concerns, which carry higher margins and drive provider engagement. Geographically, the Americas account for roughly 65% of revenue, EMEA roughly 25%, and APAC roughly 10%. Beauty Health also offers SkinStylus, a microneedling platform acquired in 2023, as a complementary provider treatment, though it remains a small part of the business.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →